K2 toxicity: fatal case of psychiatric complications following AM2201 exposure.
about
NPS: Medical Consequences Associated with Their IntakeDistinct pharmacology and metabolism of K2 synthetic cannabinoids compared to Δ(9)-THC: mechanism underlying greater toxicity?Using poisons information service data to assess the acute harms associated with novel psychoactive substances.The K2/Spice phenomenon: emergence, identification, legislation and metabolic characterization of synthetic cannabinoids in herbal incense products.Metabolite profiling of RCS-4, a novel synthetic cannabinoid designer drug, using human hepatocyte metabolism and TOF-MS.High-resolution mass spectrometric determination of the synthetic cannabinoids MAM-2201, AM-2201, AM-2232, and their metabolites in postmortem plasma and urine by LC/Q-TOFMS.A systematic review of adverse events arising from the use of synthetic cannabinoids and their associated treatment.High-resolution mass spectrometric metabolite profiling of a novel synthetic designer drug, N-(adamantan-1-yl)-1-(5-fluoropentyl)-1H-indole-3-carboxamide (STS-135), using cryopreserved human hepatocytes and assessment of metabolic stability with humSynthetic cannabinoids: epidemiology, pharmacodynamics, and clinical implications.Novel psychoactive substances of interest for psychiatry.Nontargeted SWATH acquisition for identifying 47 synthetic cannabinoid metabolites in human urine by liquid chromatography-high-resolution tandem mass spectrometry.Comprehensive review of the detection methods for synthetic cannabinoids and cathinones.Quantification of [1-(5-fluoropentyl)-1H-indol-3-yl](naphthalene-1-yl)methanone (AM-2201) and 13 metabolites in human and rat plasma by liquid chromatography-tandem mass spectrometry.Toxicology and management of novel psychoactive drugs.The adverse health effects of synthetic cannabinoids with emphasis on psychosis-like effects.Synthetic cannabinoids pharmacokinetics and detection methods in biological matrices.Acute effects of synthetic cannabinoids: Update 2015.Pharmacological and Toxicological Effects of Synthetic Cannabinoids and Their Metabolites.Distribution of Synthetic Cannabinoids JWH-210, RCS-4 and Δ 9-Tetrahydrocannabinol After Intravenous Administration to Pigs.Analysis of AM-2201 and metabolites in a drugs and driving case.Teens and Spice: A Review of Adolescent Fatalities Associated with Synthetic Cannabinoid Use.Pharmaco-toxicological effects of the novel third-generation fluorinate synthetic cannabinoids, 5F-ADBINACA, AB-FUBINACA, and STS-135 in mice. In vitro and in vivo studies.AM-2201 Inhibits Multiple Cytochrome P450 and Uridine 5'-Diphospho-Glucuronosyltransferase Enzyme Activities in Human Liver Microsomes.Cytochrome P450-mediated metabolism of the synthetic cannabinoids UR-144 and XLR-11
P2860
Q28276182-D93C5306-C9BE-40C4-AF3B-2F72843B5D81Q28540537-2C4975D6-AD55-4B73-9453-73E106687509Q30821795-5D8C236D-140F-44DB-A0B9-EECF05218ECAQ33908169-3AD46AA1-A365-4C12-A02F-AE29FCDE637AQ34156299-B8798379-3522-43C1-B8F7-05E7F1225982Q34493135-EFBED48B-9A45-474F-BD97-8B59EEED5DA1Q34501742-7E853D93-3816-4482-8B61-4C4E616AFAA6Q34514221-F31F77E6-05F2-4636-92F4-31AAAAD3EFA8Q34617484-DC37FC53-F9D5-46B2-9E43-5DE1B4CA8B75Q34667835-0027A391-22CB-42FA-B95C-A70FF89E9340Q35254099-3C6B2370-A180-4323-8215-B4BEC4B84E77Q35917163-6DAAAC3C-3E52-4FF2-AED1-3E787E97D152Q36950560-0734EDDD-A774-46E2-B161-B35E139C500CQ38254814-6DF734E5-3F1A-4669-ACB2-5722967DA79DQ38317405-779E841E-D62F-48FA-9671-59D14C756410Q38411456-E6F02042-9EE4-49C1-AEE7-708902B81971Q38974969-BE5711DC-8F30-48B4-8A2F-5AA0FB8A7D55Q39052265-706CAF71-7C48-4588-B115-06E48407B0A4Q39196884-5E85F9B2-9391-41D5-A68E-EDA99CF984CCQ45066806-A09A0CB7-837D-49DE-8372-9A9AF96ABEE2Q47203043-00515FEF-0113-4134-BA75-3BFA25332702Q48301733-9BB1869B-C39E-4D26-BAAA-B633DE6233E0Q51100761-E1DB4ABC-1DBE-47E0-B89A-9B13572A304EQ57814871-D005FC6C-7F73-49FA-8552-E211C7DBDCBA
P2860
K2 toxicity: fatal case of psychiatric complications following AM2201 exposure.
description
2013 nî lūn-bûn
@nan
2013 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
K2 toxicity: fatal case of psychiatric complications following AM2201 exposure.
@ast
K2 toxicity: fatal case of psychiatric complications following AM2201 exposure.
@en
type
label
K2 toxicity: fatal case of psychiatric complications following AM2201 exposure.
@ast
K2 toxicity: fatal case of psychiatric complications following AM2201 exposure.
@en
prefLabel
K2 toxicity: fatal case of psychiatric complications following AM2201 exposure.
@ast
K2 toxicity: fatal case of psychiatric complications following AM2201 exposure.
@en
P2093
P2860
P356
P1476
K2 toxicity: fatal case of psychiatric complications following AM2201 exposure.
@en
P2093
Amy L Patton
Anna Radominska-Pandya
Charles Kokes
Cindy L Moran
Jeffery H Moran
Keith R McCain
Krishna C Chimalakonda
Laura P James
P2860
P304
P356
10.1111/1556-4029.12216
P577
2013-07-03T00:00:00Z